| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Protalix BioTherapeutics, Inc. | Director | Common Stock | 7.5K | $11.6K | $1.55 | Sep 3, 2025 | By Trust |
| Protalix BioTherapeutics, Inc. | Director | Stock Options (Right to Buy) | 15K | Sep 3, 2025 | Direct | ||
| F-star Therapeutics, Inc. | PRESIDENT AND CEO, Director | Common Stock | 0 | $7.12 | Mar 8, 2023 | Direct | |
| F-star Therapeutics, Inc. | PRESIDENT AND CEO, Director | Stock Option (right to buy) | 0 | Mar 8, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| PLX | Protalix BioTherapeutics, Inc. | Sep 3, 2025 | 2 | $0 | 4 | Sep 4, 2025 | Director |
| PLX | Protalix BioTherapeutics, Inc. | Sep 14, 2023 | 1 | $0 | 4 | Sep 15, 2023 | Director |
| PLX | Protalix BioTherapeutics, Inc. | Sep 14, 2023 | 0 | $0 | 3 | Sep 15, 2023 | Director |
| FSTX | F-star Therapeutics, Inc. | Mar 8, 2023 | 5 | -$3M | 4 | Mar 9, 2023 | PRESIDENT AND CEO, Director |
| FSTX | F-star Therapeutics, Inc. | Jul 29, 2022 | 3 | $28.7K | 4 | Aug 2, 2022 | President and CEO, Director |
| FSTX | F-star Therapeutics, Inc. | Mar 31, 2022 | 1 | $0 | 4 | Apr 4, 2022 | President and CEO, Director |
| FSTX | F-star Therapeutics, Inc. | Jan 9, 2022 | 1 | $0 | 4 | Jan 11, 2022 | President and CEO, Director |